The new device was designed to help patients evaluate their own heart health in real time.

The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.

Will the second Trump Administration manage AI’s risks—or ‘unshackle’ AI’s potential? 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

The U.S. Food and Drug Administration issued the recall notice for more than 200,000 pacemakers because a battery issue could lock the device in safe mode. 

Remote patient monitoring helps clinicians track heart patients as they recover from major operations. One surgeon described the technology as a "game-changer," highlighting the confidence patients feel when they have "an extra set of eyes on them."  

In patients with suspected stroke, contrast allergies present a significant dilemma, as contrast-enhanced imaging is often used to guide treatment decisions.

Bottles of duloxetine manufactured by Rising Pharmaceuticals are being recalled due to higher-than-normal levels of nitrosamine contaminants. The recall is classified as Class II, the second most serious type.